KOBIE DOUGLAS: Open Payments
NPI 1497850663 · GARY, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$177 in 8 payments from 6 companies in 2025. Trend: 2023 $102 · 2024 $142 · 2025 $177
Food & beverage: $177
| Company | Payments | Amount |
|---|---|---|
| Luye Pharma (USA) Ltd. | 2 | $58 |
| Alkermes, Inc. | 2 | $32 |
| Janssen Pharmaceuticals, Inc | 1 | $28 |
| E.R. Squibb & Sons, L.L.C. | 1 | $24 |
| Teva Pharmaceuticals USA, Inc. | 1 | $19 |
| Neurocrine BioSciences, Inc. | 1 | $17 |
Products named: ERZOFRI EXTENDED-RELEASE, SPRAVATO, COBENFY, AUSTEDO XR, VIVITROL, INGREZZA, ARISTADA.
Industry payments across IN — which companies pay providers there.
